|
3 Companies |
|
2 Products |
|
2 Products |
|
7 Mechanisms of Action |
|
0 Trials |
|
25 News |
|
- | Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. (clinicaltrials.gov) - Feb 18, 2019
P1, N=1, Terminated, Sponsor: Johns Hopkins University
N=36 --> 1 | Trial completion date: Feb 2021 --> Nov 2017 | Suspended --> Terminated | Trial primary completion date: Feb 2020 --> Nov 2017; Device manufacturer no longer supports implant covered under the IDE.
- | Trial suspension: Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. (clinicaltrials.gov) - Nov 13, 2017
P1, N=36, Suspended, Sponsor: Johns Hopkins University
N=36 --> 1 | Trial completion date: Feb 2021 --> Nov 2017 | Suspended --> Terminated | Trial primary completion date: Feb 2020 --> Nov 2017; Device manufacturer no longer supports implant covered under the IDE. Recruiting --> Suspended
- | Trial completion, Trial primary completion date: A Nasal Applicator for the Treatment of Trigeminal Neuralgia (clinicaltrials.gov) - Sep 14, 2017
P=N/A, N=10, Completed, Sponsor: Chicago Anesthesia Pain Specialists
Recruiting --> Suspended Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Sep 2017
- Trial primary completion date: A Nasal Applicator for the Treatment of Trigeminal Neuralgia (clinicaltrials.gov) - Feb 1, 2017
P=N/A, N=10, Active, not recruiting, Sponsor: Chicago Anesthesia Pain Specialists
Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Sep 2017 Trial primary completion date: Dec 2016 --> Jun 2017
- Enrollment closed, Trial primary completion date: A Nasal Applicator for the Treatment of Trigeminal Neuralgia (clinicaltrials.gov) - Aug 10, 2016
P=N/A, N=10, Active, not recruiting, Sponsor: Chicago Anesthesia Pain Specialists
Trial primary completion date: Dec 2016 --> Jun 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
- Trial completion, Enrollment change: Hippocampal Radiation Exposure and Memory (clinicaltrials.gov) - Jun 23, 2016
P=N/A, N=1, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Completed | N=30 --> 1
- Trial primary completion date: A Nasal Applicator for the Treatment of Trigeminal Neuralgia (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=10, Recruiting, Sponsor: Chicago Anesthesia Pain Specialists
Recruiting --> Completed | N=30 --> 1 Trial primary completion date: Apr 2015 --> Dec 2015
- Enrollment open: Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. (clinicaltrials.gov) - Jul 21, 2015
P1, N=36, Recruiting, Sponsor: Johns Hopkins University
Trial primary completion date: Apr 2015 --> Dec 2015 Not yet recruiting --> Recruiting
- Enrollment change, Trial withdrawal: CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=0, Withdrawn, Sponsor: St. Olavs Hospital
Not yet recruiting --> Recruiting N=400 --> 0 | Active, not recruiting --> Withdrawn
- Trial primary completion date: A Nasal Applicator for the Treatment of Trigeminal Neuralgia (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=10, Recruiting, Sponsor: Chicago Anesthesia Pain Specialists
N=400 --> 0 | Active, not recruiting --> Withdrawn Trial primary completion date: Dec 2014 --> Apr 2015
- | New P1 trial: Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. (clinicaltrials.gov) - Dec 22, 2014
P1, N=36, Not yet recruiting, Sponsor: Johns Hopkins University
- |||| vixotrigine (BIIB074) / Biogen, GSK
Trial completion, Enrollment change: A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia (clinicaltrials.gov) - Oct 30, 2014
P2a, N=67, Completed, Sponsor: Convergence Pharmaceuticals
Trial primary completion date: Dec 2014 --> Apr 2015 Active, not recruiting --> Completed | N=30 --> 67
- Enrollment closed: CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap (clinicaltrials.gov) - Jul 30, 2014
P=N/A, N=400, Active, not recruiting, Sponsor: St. Olavs Hospital
Active, not recruiting --> Completed | N=30 --> 67 Recruiting --> Active, not recruiting
- Trial withdrawal: Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain (clinicaltrials.gov) - Mar 11, 2014
P2/3, N=0, Withdrawn, Sponsor: Allodynic Therapeutics, LLC
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- Enrollment change: Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain (clinicaltrials.gov) - Mar 11, 2014
P2/3, N=0, Withdrawn, Sponsor: Allodynic Therapeutics, LLC
Not yet recruiting --> Withdrawn N=50 --> 0
- Enrollment open: CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap (clinicaltrials.gov) - Feb 26, 2014
P=N/A, N=400, Recruiting, Sponsor: St. Olavs Hospital
N=50 --> 0 Not yet recruiting --> Recruiting
- | vixotrigine (BIIB074) / Biogen, GSK
Enrollment closed: A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia (clinicaltrials.gov) - Jan 6, 2014
P2a, N=30, Active, not recruiting, Sponsor: Convergence Pharmaceuticals
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- New P2/3 trial: Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain (clinicaltrials.gov) - Aug 7, 2013
P2/3, N=0, Withdrawn, Sponsor: Allodynic Therapeutics, LLC
- Trial completion: Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain (clinicaltrials.gov) - Dec 25, 2012
P4, N=16, Completed, Sponsor: Sheba Medical Center
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial withdrawal: Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception (clinicaltrials.gov) - Apr 25, 2012
P2/3, N=0, Withdrawn, Sponsor: Medical University of South Carolina
Recruiting --> Completed Recruiting --> Withdrawn
- Enrollment change: Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception (clinicaltrials.gov) - Apr 25, 2012
P2/3, N=0, Withdrawn, Sponsor: Medical University of South Carolina
Recruiting --> Withdrawn N=180 --> 0
- |||| artemether/lumefantrine / Generic mfg.
Trial completion: A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®) (clinicaltrials.gov) - Apr 22, 2012
P4, N=14075, Completed, Sponsor: Novartis
N=180 --> 0 Recruiting --> Completed
- | vixotrigine (BIIB074) / Biogen, GSK
New P2a trial: A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia (clinicaltrials.gov) - Feb 27, 2012
P2a, N=30, Active, not recruiting, Sponsor: Convergence Pharmaceuticals
- New P4 trial: Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain (clinicaltrials.gov) - Oct 3, 2011
P4, N=16, Completed, Sponsor: Sheba Medical Center